参考文献/References:
[1] 中国研究型医院学会脑小血管病专业委员会,《中国脑小血管病诊治专家共识》编写组. 中国脑小血管病诊治专家共识2021[J]. 中国卒中杂志,2021,16(7):716-726.
[2] Cannistraro RJ, Badi M, Eidelman BH, et al. CNS small vessel disease: a clinical review [J]. Neurology, 2019, 92(24): 1146-1156.
[3] Saridin FN, Hilal S, Villaraza SG, et al. Brain amyloid β,cerebral small vessel disease, and cognition: a memory clinic study [J]. Neurology, 2020, 95(21): e2845-e2853.
[4] Peters N, van Leijsen E, Tuladhar AM, et al. Serum neurofilament light chain is associated with incident lacunes in progressive cerebral small vessel disease [J]. J Stroke, 2020, 22(3): 369-376.
[5] Moscoso A, Grothe MJ, Ashton NJ, et al. Longitudinal asso-ciations of blood phosphorylated tau181 and neurofilament light chain with neurodegeneration in alzheimer disease [J]. JAMA Neurol, 2021, 78(4): 396-406.
[6] Andersson E, Janelidze S, Lampinen B, et al. Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer's disease [J]. Neuro-biol Aging, 2020, 95: 143-153.
[7] He L, de Souto Barreto P, Aggarwal G, et al. Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults [J]. Alzheimers Res Ther, 2020, 12(1): 128.
[8] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国脑小血管病诊治共识[J]. 中华神经科杂志,2015,48(10):838-844.
[9] Assadi G. The mental state examination [J]. Br J Nurs, 2020, 29(22): 1328-1332.
[10] Teng Z, Dong Y, Zhang D, et al. Cerebral small vessel disease and post-stroke cognitive impairment [J]. Int J Neuro-sci, 2017, 127(9): 824-830.
[11] Biesbroek JM, Weaver NA, Biessels GJ. Lesion location and cognitive impact of cerebral small vessel disease [J]. Clin Sci (Lond), 2017, 131(8): 715-728.
[12] Wallin A, Román GC, Esiri M, et al. Update on vascular cognitive impairment associated with subcortical small-vessel disease [J]. J Alzheimers Dis, 2018, 62: 1417-1441.
[13] Chen X, Wang J, Shan Y, et al. Cerebral small vessel disease: neuroimaging markers and clinical implication [J]. J Neurol, 2019, 266(10): 2347-2362.
[14] Gattringer T, Pinter D, Enzinger C, et al. Serum neurofilament light is sensitive to active cerebral small vessel disease[J]. Neurology, 2017, 89(20): 2108-2114.
[15] 陈绍辉,刘少列,陈耿春,等. 尿液神经丝蛋白水平与脑小血管病的关系[J]. 卒中与神经疾病,2020,27:614-617.
[16] Qu Y, Tan CC, Shen XN, et al. Association of plasma neuro-filament light with small vessel disease burden in nondemented elderly: a longitudinal study [J]. Stroke, 2021, 52(3): 896-904.
[17] Liu Q, Liao X, Pan Y, et al. Association between serum uric acid levels and cognitive function in patients with ischemic stroke and transient ischemic attack (TIA): a 3-month follow-up study [J]. Neuropsychiatr Dis Treat, 2021, 17: 991-999.
[18] 李 睿,胡珂宇,赵景茹,等. 脑小血管病患者血尿酸与认知功能的研究[J]. 河北医药,2019,41(5):679-682.
相似文献/References:
[1]刘青云 刘 俊 钟群琼 於 胜 隗世波.颅脑损伤患者血清甲状腺素和和肽素的变化[J].中国临床神经外科杂志,2017,(03):155.[doi:10.13798/j.issn.1009-153X.2017.03.009]
Liu Qin-yun,LIU Jun,ZHONG Qun-qiong,et al.Changes in serum levels of thyroid hormones and copeptin in patients with severe traumatic brain injury[J].,2017,(06):155.[doi:10.13798/j.issn.1009-153X.2017.03.009]
[2]武元星 郝京京 王 强.血清及脑脊液降钙素原在神经外科术后颅内感染早期诊断中的应用[J].中国临床神经外科杂志,2017,(04):237.[doi:10.13798/j.issn.1009-153X.2017.04.010]
WU Yuan-xing,HAO Jing-jing,WANG Qiang..Value of procalcitonin in serum and cerebrospinal fluid to diagnosis of intracranial infection early after craniotomy[J].,2017,(06):237.[doi:10.13798/j.issn.1009-153X.2017.04.010]
[3]杨文进 郭义君 童武松 郑 平 汪瑞忠 焦荣红 何 斌 陈 磊.急性颅脑损伤后早期血清Tau蛋白的动态变化及临床意义[J].中国临床神经外科杂志,2017,(08):536.[doi:10.13798/j.issn.1009-153X.2017.08.004]
YANG Wen-jin,GUO Yi-jun,TONG Wu-song,et al.Dynamic change in serum level of tau protein and its clinical meanings in patients with acute traumatic brain injury[J].,2017,(06):536.[doi:10.13798/j.issn.1009-153X.2017.08.004]
[4]朱郭婷 陈思思 黄书岚.血清淀粉样蛋白A与自发性脑出血预后的关系[J].中国临床神经外科杂志,2017,(08):539.[doi:10.13798/j.issn.1009-153X.2017.08.005]
ZHU Guo-ting,CHEN Si-si,HUANG Shu-lan..Relationship of serum level of amyloid protein A with prognoses in patients with acute spontaneous intracerebral hemorrhage[J].,2017,(06):539.[doi:10.13798/j.issn.1009-153X.2017.08.005]
[5]阮 东 王 芳 郭丽蕊 彭红梅 陈谦学 刘宝辉.C-反应蛋白与动脉瘤性蛛网膜下腔出血临床预后的关系[J].中国临床神经外科杂志,2017,(09):626.[doi:10.13798/j.issn.1009-153X.2017.09.006]
RUAN Dong,WANG Fang,GUO Li-rui,et al.Relationship between serum level of C-reactive protein and prognoses in patients with aneurysmal subarachnoid hemorrhage[J].,2017,(06):626.[doi:10.13798/j.issn.1009-153X.2017.09.006]
[6]李建军.血清NSE与颅脑损伤术后早期颅内压增高-累计时间的相关性[J].中国临床神经外科杂志,2018,(02):78.
LI Jian-jun..Correlativity of serum level of neuron specific enolase with pressure times time dose of intracranial pressure in patients with severe traumatic brain injury[J].,2018,(06):78.
[7]何一川 高博文 综述 于耀宇 审校.脑小血管病诊断及治疗现状[J].中国临床神经外科杂志,2018,(04):292.[doi:10.13798/j.issn.1009-153X.2018.04.025]
[8]孙瑞迅 李琳坤 董 辉 刘 飒.脑胶质瘤病人SII、血清Fib和AGR水平变化及意义[J].中国临床神经外科杂志,2020,(04):209.[doi:10.13798/j.issn.1009-153X.2020.04.006]
SUN Rui-xun,LI Lin-kun,DONG Hui,et al.Changes of SII, serum levels of Fib and AGR and their clinical significances in patients with gliomas[J].,2020,(06):209.[doi:10.13798/j.issn.1009-153X.2020.04.006]
[9]王 阳 平建峰 刘会星.缺血性脑卒中后认知功能障碍病人血清胱抑素-C水平变化及其意义[J].中国临床神经外科杂志,2020,(04):212.[doi:10.13798/j.issn.1009-153X.2020.04.007]
WANG Yang,PING Jian-feng,LIU Hui-xing..Change of serum level of cystatin C and its meanings in patients with cognitive dysfunction after ischemic stroke[J].,2020,(06):212.[doi:10.13798/j.issn.1009-153X.2020.04.007]
[10]刘雪艳 刘利娟 童海婷.重型颅脑损伤血清Caspase-3的水平变化及其意义[J].中国临床神经外科杂志,2020,(04):215.[doi:10.13798/j.issn.1009-153X.2020.04.008]
LIU Xue-yan,LIU Li-juan,TONG Hai-ting..Change of serum level of Caspase-3 and its clinical meanings in patients with severe traumatic brain injury[J].,2020,(06):215.[doi:10.13798/j.issn.1009-153X.2020.04.008]